chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Chills, Fatigue, Headache, Myalgia
Clinical narrative: Fever; muscle aches; nausea; chills; chest tightness (hard to take deep breathe); fatigue; head ache; This is a spontaneous report from a non-contactable consumer (husband). A 41-years-old non pregnant female patient received bnt162b2 (COMIRNATY, Solution for injection, Batch/Lot Number: EP6955) dose 2 via an unspecified route of administration, administered in Arm Left on 13Apr2021 10:00 as DOSE 2, SINGLE for covid-19 immunisation (at the age of 41 years). Medical history included, food allergy (shellfish) from an unknown date and unknown if ongoing. Concomitant medications included essential oils nos, Nuva ring (ETHINYLESTRADIOL, ETONOGESTREL), multi-vitamins, probiotics taken for an unspecified indication, start and stop date were not reported. The patient previously took first dose of bnt162b2 (COMIRNATY, Solution for injection, Batch/Lot Number: EP6955) via an unspecified route of administration, administered in Arm Left on 23Mar2021 09:30 AM as DOSE 1, SINGLE for covid-19 immunisation. The patient was not pregnant at time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior vaccine and post vaccine the patient was not diagnosed with COVID-19. The patient experienced fever, muscle aches, chills, chest tightness (hard to take deep breathe), fatigue, headache on 14Apr2021. No treatment was received for the adverse events. The clinical outcome of the events were recovering.  No follow-up attempts possible. No further information expected. bnt162b2 batch cannot be obtained.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pyrexia
Clinical narrative: Fever; muscle aches; nausea; chills; chest tightness (hard to take deep breathe); fatigue; head ache; This is a spontaneous report from a non-contactable consumer (husband). A 41-years-old non pregnant female patient received bnt162b2 (COMIRNATY, Solution for injection, Batch/Lot Number: EP6955) dose 2 via an unspecified route of administration, administered in Arm Left on 13Apr2021 10:00 as DOSE 2, SINGLE for covid-19 immunisation (at the age of 41 years). Medical history included, food allergy (shellfish) from an unknown date and unknown if ongoing. Concomitant medications included essential oils nos, Nuva ring (ETHINYLESTRADIOL, ETONOGESTREL), multi-vitamins, probiotics taken for an unspecified indication, start and stop date were not reported. The patient previously took first dose of bnt162b2 (COMIRNATY, Solution for injection, Batch/Lot Number: EP6955) via an unspecified route of administration, administered in Arm Left on 23Mar2021 09:30 AM as DOSE 1, SINGLE for covid-19 immunisation. The patient was not pregnant at time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior vaccine and post vaccine the patient was not diagnosed with COVID-19. The patient experienced fever, muscle aches, chills, chest tightness (hard to take deep breathe), fatigue, headache on 14Apr2021. No treatment was received for the adverse events. The clinical outcome of the events were recovering.  No follow-up attempts possible. No further information expected. bnt162b2 batch cannot be obtained.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Fatigue, Headache, Night sweats
Clinical narrative: Severe chills; Fever; Vomiting; Diarrhea; Fatigue; Headache; Increased tinnitus; Night sweats; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the right arm on 12Apr2021 at 11:15 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. Medical history included pre-diabetic and allergy to sulpha drugs. Prior to vaccination, the patient was not diagnosed with COVID -19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included rosuvastatin calcium (MANUFACTURER UNKNOWN) and hydrochlorothiazide, olmesartan medoxomil (BENICAR HCT), both taken for unknown indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204) via an unspecified route of administration in the right arm on 22Mar2021 at 16:30 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. On 12Apr2021 at 23:00, the patient experienced severe chills, fever, vomiting, diarrhea, fatigue, headache, increased tinnitus and night sweats. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events severe chills, fever, vomiting, diarrhea, fatigue, headache, increased tinnitus and night sweats were recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Tinnitus, Vomiting
Clinical narrative: Severe chills; Fever; Vomiting; Diarrhea; Fatigue; Headache; Increased tinnitus; Night sweats; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the right arm on 12Apr2021 at 11:15 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. Medical history included pre-diabetic and allergy to sulpha drugs. Prior to vaccination, the patient was not diagnosed with COVID -19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included rosuvastatin calcium (MANUFACTURER UNKNOWN) and hydrochlorothiazide, olmesartan medoxomil (BENICAR HCT), both taken for unknown indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204) via an unspecified route of administration in the right arm on 22Mar2021 at 16:30 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. On 12Apr2021 at 23:00, the patient experienced severe chills, fever, vomiting, diarrhea, fatigue, headache, increased tinnitus and night sweats. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events severe chills, fever, vomiting, diarrhea, fatigue, headache, increased tinnitus and night sweats were recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Contusion, Fatigue, Feeling cold, Headache, Lymphadenopathy
Clinical narrative: Cold sensation over entire body; Body Aches; sever headache; swollen lymph node under left arm/next morning still had swollen lymph node and redish bruising under arm in armpit; fatigue; redish bruising; This is a spontaneous report from a contactable consumer or other non hcp. A 28-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration, administered in Arm Left on 18Apr2021 16:45 (Age at Vaccination 28-years-old) as DOSE NUMBER UNKNOWN, SINGLE for COVID-19 immunization. Medical history included Allergies to medications, food, or other products:percoset, vicodin, alieve, codine, zythromax, osmopret, bactrim, ceftriaxone, bee stings. Concomitant medications included spironolactone; doxycycline; norethindrone taken for an unspecified indication, start and stop date were not reported. The patient experienced cold sensation over entire body, body aches , sever headache, swollen lymph node under left arm/next morning still had swollen lymph node and redish bruising under arm in armpit , fatigue, redish bruising on 18Apr2021 16:45. No treatment were provided for the events. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 19Apr2021 hcp became aware of the events. The patient was not tested covid prior or post vaccination. The clinical outcome of the events was unknown.  No follow-up attempts are needed, information about lot/batch number cannot be obtained.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: Cold sensation over entire body; Body Aches; sever headache; swollen lymph node under left arm/next morning still had swollen lymph node and redish bruising under arm in armpit; fatigue; redish bruising; This is a spontaneous report from a contactable consumer or other non hcp. A 28-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration, administered in Arm Left on 18Apr2021 16:45 (Age at Vaccination 28-years-old) as DOSE NUMBER UNKNOWN, SINGLE for COVID-19 immunization. Medical history included Allergies to medications, food, or other products:percoset, vicodin, alieve, codine, zythromax, osmopret, bactrim, ceftriaxone, bee stings. Concomitant medications included spironolactone; doxycycline; norethindrone taken for an unspecified indication, start and stop date were not reported. The patient experienced cold sensation over entire body, body aches , sever headache, swollen lymph node under left arm/next morning still had swollen lymph node and redish bruising under arm in armpit , fatigue, redish bruising on 18Apr2021 16:45. No treatment were provided for the events. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 19Apr2021 hcp became aware of the events. The patient was not tested covid prior or post vaccination. The clinical outcome of the events was unknown.  No follow-up attempts are needed, information about lot/batch number cannot be obtained.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Pruritus, Rash, SARS-CoV-2 test
Clinical narrative: I broke out in a rash on most parts of my body; arms, legs, back, and buttocks/ Bad rash all over my body; will not go; The rash itches very bad, I scratch at it and it gets worse and seems to spread to more parts of my body; This is a spontaneous report from a contactable consumer (patient) reported for himself. A 60-years-old male patient received BNT162B2 (Pfizer-Biontech COVID-19 Vaccine, Solution for injection, batch/lot number: EN6204), via an unknown route of administration in right arm on 25Mar2021 at 09:00 (at the age of 60-years-old) as dose 2, single for COVID-19 immunization at pharmacy. The patient's medical history included COVID-19 from an unknown date. No allergies to medications, food, or other products. Other medical history was none. Concomitant medication was not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. No, any other medications he received within 2 weeks of vaccination. The patient received BNT162B2 (Pfizer-Biontech COVID-19 Vaccine, Solution for injection, batch/lot number: EN6206) in left arm on 04Mar2021 at 08:45 (at the age of 60-years-old) as historical vaccine as dose 1, single for COVID-19 immunization. On 01Apr2021 at 14:30, the patient broke out in a rash on most parts of his body; arms, legs, back, and buttocks. Rash would not go away, his doctor prescribed some ointment, but it has not helped much, the rash itches very bad, he scratch at it and it gets worse and seems to spread to more parts of his body. On 05Apr2021 at 18:00, bad rash all over his body; will not go away. The adverse event result to visit doctor or other healthcare professional office or clinic. On 21Apr2021, the patient had COVID test post vaccination by mouth swab, resulted in negative. Triamcinolone and steroid shot were received as treatment for the adverse event. The outcome of events was not recovered.  Follow-up attempts are completed. No further information is expected.
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Hypersensitivity, Hypoaesthesia, Hypoaesthesia oral
Clinical narrative: Allergic reaction, started with mouth and nose going numb for 1st injection; Allergic reaction, started with mouth and nose going numb for 1st injection; Allergic reaction, started with mouth and nose going numb for 1st injection; This is a spontaneous report received from a contactable consumer (patient) reported for himself. A 41-years-old male patient received BNT162B2 (Pfizer-Biontech COVID-19 Vaccine, solution for injection, batch/lot number: FR8730), via an unknown route of administration in left arm on 24Mar2021 at 10:00 (at the age of 41-years-old) as dose 1, single for COVID-19 immunization at hospital. The patient's medical history included asthma and had no allergies to medications, food, or other products. Concomitant medication included tizanidine (MANUFACTURER UNKNOWN) from an unknown date for an unknown indication. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 24Mar2021, the patient experienced allergic reaction, started with mouth and nose going numb for 1st injection. Before the 1st injection he had never had an allergic reaction. Patient had not been diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination. No treatment received for the adverse event. The outcome of events was recovered on an unknown date in 2021.  Follow-up attempts completed. No further information expected.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Headache, Malaise, Nausea, Pyrexia
Clinical narrative: Felling of being unwell; Feverish; Diarrhea; Began with a slight headache, then Nausea the first evening. The second day started with Nausea, feverish, diarrhea. Continued with a general feeling of being unwell on the 3rd day (nausea, diarrhea,; Nausea; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an unspecified route of administration in the arm right on 14Apr2021 at 17:30(at the age of 47-years-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included levothyroxine sodium (SYNTHROID) from an unknown date for an unknown indication and unknown if ongoing. On 14Apr2021 at 20:00, the patient reported that it began with a slight headache, then nausea the first evening and the second day started with nausea, feverish, diarrhea, continued with a general feeling of being unwell on the 3rd day (nausea, diarrhea, but no headache). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events began with a slight headache and feverish was recovered on unknown date in Mar2021. The clinical outcome of the events, nausea, diarrhea and feeling of being unwell was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Renal pain
Clinical narrative: Severe kidney pain; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 14Apr2021 at 16:00 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19.  Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN), bupropion hydrochloride (WELLBUTRIN), LEXUS PRO and ethinylestradiol/etonogestrel (NUVARING); all for unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 23Mar2021 at 16:00 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. On 16Apr2021, the patient experienced severe kidney pain. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event severe kidney pain was not recovered at the time of this report.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Pain, Pyrexia
Clinical narrative: Chills; Fever; Body pain; Fatigue; This is a spontaneous report from a non-contactable consumer, the patient. A 35-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Ew0164) via an unspecified route of administration in the right arm on 17Apr2021 at 17:30 (at the age of 35-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient received other vaccine within four weeks of COVID-19 vaccine. The patient did not received any other medications in two weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Er8733) via an unspecified route of administration in the right arm on 29Mar2021 (at the age of 35-year-old) as a single dose for COVID-19 immunisation. On 18Apr2021 at 03:00, the patient experienced chills, fever, body pain and fatigue. The events did not result in doctor or other healthcare professional office or clinic visit, emergency room or department or urgent care. No therapeutic measures were taken as a result of the adverse events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events chills, fever, body pain and fatigue were not recovered at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Fatigue, Pharyngeal swelling, Sinus congestion
Clinical narrative: Trouble breathing; Throat was a little swollen; Sinuses were stuffy; Got tired and went to bed; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ERB737) via an unspecified route of administration in the left arm on 13Apr2021 at 14:00 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure, diabetes 2 (type 2 diabetes mellitus) and knee arthritis. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included metoprolol (MANUFACTURER UNKNOWN), hydrochlorothiazide / losartan potassium (LOSARTAN/HCTZ), diltiazem (MANUFACTURER UNKNOWN), and glibenclamide (GLYBURIDE); all for an unknown indication from an unknown date and unknown if ongoing. On 13Apr2021, at approximately 21:00, the patient got tired and went to bed. On 14Apr2021, at 00:00 the patient woke up at mid-night and experienced trouble breathing and also felt like throat was a little swollen, but had no problem in swallowing, sinuses were stuffy but had no allergies and no sinus problems before. The patient sat up the rest of the night and the breathing got better. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events got tired, trouble breathing, throat was a little swollen, and sinuses were stuffy was recovering at the time of this report.   No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Hypersensitivity, Rash
Clinical narrative: allergic reaction; rash between buttocks and legs; This is a spontaneous report from a non-contactable consumer reported for a patient. A female patient of an unknown age received BNT162B2 (Pfizer-Biontech COVID-19 Vaccine, solution for injection, batch/lot number: unknown), via an unknown route of ministration on an unknown date as dose number unknown, single for COVID-19 immunization. The patient's medical history and concomitant medication were not reported. On an unknown date, the patient experienced allergic reaction some days after vaccination, she had a rash between buttocks and legs. The outcome of events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Diarrhoea, Headache, Nausea
Clinical narrative: 100 degrees fever; Nausea; Chills; Diarrhea; Unusually strong headache; This is a spontaneous report from a non-contactable consumer, the patient. A 25-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 15Apr2021 at 15:00 (at the age of 25-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive any concomitant medications. On 16Apr2021, at 09:00, the patient experienced 100 degrees fever, nausea, chills, diarrhea and unusually strong headache. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events 100 degrees fever, nausea, chills, diarrhea and unusually strong headache was recovering at the time of report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: 100 degrees fever; Nausea; Chills; Diarrhea; Unusually strong headache; This is a spontaneous report from a non-contactable consumer, the patient. A 25-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 15Apr2021 at 15:00 (at the age of 25-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive any concomitant medications. On 16Apr2021, at 09:00, the patient experienced 100 degrees fever, nausea, chills, diarrhea and unusually strong headache. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events 100 degrees fever, nausea, chills, diarrhea and unusually strong headache was recovering at the time of report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Body temperature, Headache, Pyrexia, Renal pain
Clinical narrative: Fever of 101.3, joint pain throughout body, pain in kidney area, severe headache; Joint pain throughout body; Pain in kidney area; Severe headache; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the arm left on 14Apr2021 at 11:15 (at the age of 46-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported.  Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included sertraline (MANUFACTURER UNKNOWN) and vitamin d nos (MANUFACTURER UNKNOWN) all from unknown date for unknown indication and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the arm left on 17Mar2021 at 11:15 (at the age of 46-year-old) as a single dose for COVID-19 immunisation. On 15Apr2021 at 03:00, the patient experienced fever of 101.3, joint pain throughout body, pain in kidney area and severe headache and on the same day, the patient underwent body temperature test and the result was 101.3 (unspecified unit). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events, fever of 101.3, joint pain throughout body, pain in kidney area and severe headache was recovered on unknown date on Apr2021.   No follow-up attempts are needed. No further information is expected.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Myalgia
Clinical narrative: Severe headache; Chills; Muscle aches; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the left arm on 14Apr2021 at 09:00 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient had no known allergies to medications, food or other products. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received other medicines (unspecified) within two weeks prior to the COVID-19 vaccine. On 15Apr2021 at 05:00, the patient experienced severe headache, chills and muscle aches. The events did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of events and included treatment with extra-strength acetaminophen (TYNELOL). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event severe headache, chills and muscle aches was recovered on an unknown date in Apr2021.   No follow-up attempts are needed. No further information is expected.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Lymph node pain, Lymphadenopathy
Clinical narrative: Swelling of R lymph nodes; Swelling of R lymph nodes resulting in severe pain; This is a spontaneous report from a contactable healthcare professional. A 29-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EH9899) via an unspecified route of administration in the arm right on 13Jan2021 at 17:45 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Medical history included irritable bowel syndrome, depression, patellar instability, milk soy allergy, adhesive allergy, allergy to dogs and cats, beeswax allergy. The patient previously received cefalexin(CEPHALEXIN) and cortisone injection(MANUFACTURER UNKNOWN) on an unknown date for unknown indication and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included escitalopram oxalate (LEXAPRO), cetirizine hydrochloride (ZYRTEC) and birth control pill (MANUFACTURER UNKNOWN); all from unknown date for an unknown indication and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3248) via an unspecified route of administration in the arm left at 16:45 (at the age of 29-years-old) on 23Dec2020 as a single dose for COVID-19 immunisation.  On 13Jan2021 at 22:15 the patient experienced swelling of R lymph nodes resulting in severe pain. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event swelling of R lymph nodes resulting in severe pain was recovered in 3 weeks post-vaccine on an unknown date in 2021.    No follow-up attempts are needed. No further information is expected.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Pain, Pyrexia
Clinical narrative: Aches; Chills; Slight fever; Diarrhea; This is a spontaneous report from a contactable consumer, the patient. A 26-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the right arm on 15Apr2021 at 13:30 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the vaccination. Concomitant medications included melatonin (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date and unknown if ongoing. On 15Apr2021 at 17:00, the patient experienced aches, chills, slight fever and diarrhea. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events aches, chills, slight fever and diarrhea was recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Gastrooesophageal reflux disease, Headache, Pain, Pain in jaw, Vomiting
Clinical narrative: vomiting uncontrollably; acid reflux; severe headache; very achy all over; noticeable pain in jaw; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 14Apr2021 at 09:00 (at the age of 54-year-old) as a single dose for COVID-19 immunisation. Medical history included fatty liver disease, high cholesterol and overweight. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medications included paracetamol (TYLENOL) and ascorbic acid; cyanocobalamin; ergocalciferol; nicotinamide; pyridoxine hydrochloride; retinol; riboflavin; thiamine mononitrate (ONE-A-DAY), both from unknown dates for unknown indications and unknown if ongoing. On 15Apr2021 at 07:00, the patient experienced severe headache, very achy all over, noticeable pain in jaw but was still able to work and function. On the same day at 21:00, the patient experienced acid reflux and 5 minutes later at 21:05, the patient was vomiting uncontrollably. The patient fell asleep at 23:00 and woke up on 16Apr2021 feeling fine, no symptoms. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The patient did not receive any treatment for the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events severe headache, very achy all over, noticeable pain in jaw, acid reflux and vomiting uncontrollably was recovered on 16Apr2021.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Feeling abnormal, Feeling cold, Injection site swelling, Joint stiffness
Clinical narrative: Shivering; Could not get warm; Felt like hit by a truck all day today/ still feeling awful; Fever; Stiff joints; Injection site swelled up like a golf ball; This is a spontaneous report from a non-contactable consumer or other non hcp.  A 40-years-old female patient received bnt162b2 (BNT162B2),(Formulation: Solution for injection, Batch/Lot number unknown and expiration date: unknown) dose 2 SINGLE via an unspecified route of administration on 15Apr2021 for covid-19 immunisation.The patient medical history was not reported. The patient's concomitant medications were not reported. The patient Historical Vaccine was (BNT162B2Formulation: Solution for injection, Batch/Lot number unknown and expiration date: unknown) as a dose 1 single via an unspecified route of administration on an unknown date. The patient on 16Apr2021 wakes up at 2 am shivering, could not get warm, felt like hit by a truck all day today, fever, stiff joints. injection site swelled up like a golf ball, been over 24 hours and still feeling awful. The outcome of all events was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Shivering; Could not get warm; Felt like hit by a truck all day today/ still feeling awful; Fever; Stiff joints; Injection site swelled up like a golf ball; This is a spontaneous report from a non-contactable consumer or other non hcp.  A 40-years-old female patient received bnt162b2 (BNT162B2),(Formulation: Solution for injection, Batch/Lot number unknown and expiration date: unknown) dose 2 SINGLE via an unspecified route of administration on 15Apr2021 for covid-19 immunisation.The patient medical history was not reported. The patient's concomitant medications were not reported. The patient Historical Vaccine was (BNT162B2Formulation: Solution for injection, Batch/Lot number unknown and expiration date: unknown) as a dose 1 single via an unspecified route of administration on an unknown date. The patient on 16Apr2021 wakes up at 2 am shivering, could not get warm, felt like hit by a truck all day today, fever, stiff joints. injection site swelled up like a golf ball, been over 24 hours and still feeling awful. The outcome of all events was unknown.
Age: 56.0
Sex: U
Vaccine: COVID19
Symptoms: Headache, Malaise, Pain, Pain in extremity, Rash
Clinical narrative: Rashes; Headache; Arm pain; Extreme Pain all my left side that include head, face, neck, shoulder ,arm, leg and foot; Feeling so unwell; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old unknown gender patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 27Mar2021 at 14:30 (at the age of 56-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any medication within 2 weeks of vaccination. The patient previously received the first dose (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. On an unknown date in Mar2021, the patient experienced rashes, headache, arm pain, extreme pain all left side that included head, face, neck, shoulder, arm, leg and foot and felt so unwell. The patient had the events until the time of this report, 16Apr2021 (3 weeks after the last dose). The events did not result in doctor or other healthcare professional office/clinic, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events rashes, headache, arm pain, extreme pain all left side that included head, face, neck, shoulder, arm, leg and foot and felt so unwell were not recovered at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal tenderness, Depression, Diarrhoea, Feeling abnormal, Pain in extremity
Clinical narrative: Diarrhea; Tongue lesion; Tender abdomen; Bad brain fog; Depression; Sore arm; This is a spontaneous report from a non-contactable consumer, the patient. A 37-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 10Apr2021 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 10Apr2021, the patient experienced diarrhea, tongue lesion, tender abdomen, bad brain fog, depression and sore arm. The events did not result in doctor or other healthcare professional office or clinic visit, emergency room or department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events diarrhea, tongue lesion, tender abdomen, bad brain fog, depression and sore arm were resolving at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Tongue disorder
Clinical narrative: Diarrhea; Tongue lesion; Tender abdomen; Bad brain fog; Depression; Sore arm; This is a spontaneous report from a non-contactable consumer, the patient. A 37-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 10Apr2021 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 10Apr2021, the patient experienced diarrhea, tongue lesion, tender abdomen, bad brain fog, depression and sore arm. The events did not result in doctor or other healthcare professional office or clinic visit, emergency room or department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events diarrhea, tongue lesion, tender abdomen, bad brain fog, depression and sore arm were resolving at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Headache, Pain, Pollakiuria
Clinical narrative: headache; In the 12 -20 hours post injection I needed to urinate about every 45 minutes an amount inconsistently large to the amount of fluid I had taken in; 12 hours after I experienced severe chills; Body aches; Fever of 101; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER 8727) via an unspecified route of administration in the right arm on 14Apr2021 at 10:15 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. Medical history included ulcerative colitis and allergy to adhesive tape. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included fexofenadine hydrochloride (ALLEGRA), ascorbic acid, tocopheryl acetate, zinc, xantofyl, zeaxanthin (AREDS) and B-3; all for unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took ciprofloxacin (CIPRO), morphine (MANUFACTURER UNKNOWN) and mesalazine (ASACOL) and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN 6208) via an unspecified route of administration in the right arm on 24Mar2021 at 10:30 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. On 14Apr2021 at 22:30, after 12 hours of vaccination, the patient experienced severe chills, body aches, fever of 101 and nausea. On the same day the patient underwent body temperature test and the result was 101( units unspecified). In the 12 -20 hours post injection, the patient needed to urinate about every 45 minutes an amount inconsistently large to the amount of fluid had taken in. On 15Apr2021 at 05:30, about 19 hours after vaccination, she experienced a headache. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events severe chills, body aches, fever of 101, nausea and headache was recovered on 16Apr2021; while that of the event needed to urinate about every 45 minutes an amount inconsistently large to the amount of fluid was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: headache; In the 12 -20 hours post injection I needed to urinate about every 45 minutes an amount inconsistently large to the amount of fluid I had taken in; 12 hours after I experienced severe chills; Body aches; Fever of 101; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER 8727) via an unspecified route of administration in the right arm on 14Apr2021 at 10:15 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. Medical history included ulcerative colitis and allergy to adhesive tape. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included fexofenadine hydrochloride (ALLEGRA), ascorbic acid, tocopheryl acetate, zinc, xantofyl, zeaxanthin (AREDS) and B-3; all for unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took ciprofloxacin (CIPRO), morphine (MANUFACTURER UNKNOWN) and mesalazine (ASACOL) and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN 6208) via an unspecified route of administration in the right arm on 24Mar2021 at 10:30 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. On 14Apr2021 at 22:30, after 12 hours of vaccination, the patient experienced severe chills, body aches, fever of 101 and nausea. On the same day the patient underwent body temperature test and the result was 101( units unspecified). In the 12 -20 hours post injection, the patient needed to urinate about every 45 minutes an amount inconsistently large to the amount of fluid had taken in. On 15Apr2021 at 05:30, about 19 hours after vaccination, she experienced a headache. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events severe chills, body aches, fever of 101, nausea and headache was recovered on 16Apr2021; while that of the event needed to urinate about every 45 minutes an amount inconsistently large to the amount of fluid was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Contusion
Clinical narrative: Severe bruising still visible after 2 weeks of receiving vaccine.; This is a spontaneous report from a non-contactable consumer, the patient. A 69-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 01Apr2021 at 15:45 (at the age of 69-years-old) as a single dose for COVID-19 immunisation. Medical history included known allergies to sulfa and back pain. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. Concomitant medications included naproxen sodium (ALEVE), for relieve back pain from an unknown date and unknown if ongoing. The patient previously received codeine (MANUFACTURER UNKNOWN) for unknown indication on an unknown date and experienced drug allergy. On 03Apr2021, the patient experienced severe bruising still visible after 2 weeks of receiving vaccine. The patient reported that she typically never bruises. It was reported that it was maybe due to taking Aleve 200 mg, prior to relieve back pain. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the reported events. The clinical outcome of the event severe bruising was unknown at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.